Center for Immunotherapeutic Research
A partnership between the Abilene community and Texas Tech University Health Sciences
Center (TTUHSC) has resulted in the expansion of the Texas Tech School of Pharmacy
(SOP) to Abilene. As part of this expansion, the SOP will establish a Center for
Immunotherapeutic Research in Abilene, TX to conduct translational and clinical research.
The Center will be staffed by faculty investigators having diverse skills and technologies
but similar interests to discover and develop immunodiagnostics and immunotherapeutics
for the treatment of human disease, including cancer. The Center will be a model
for collaboration between different departments within the SOP, TTUHSC and with outside
institutions motivated to promote translational and clinical research.
The mission of the Center for Immunotherapeutic Research is to improve the healthcare
of people through the development and implementation of novel immune-based approaches
and methods to detect and treat human diseases.
To grow translational and clinical research in immunotherapeutics at the School of
Pharmacy through the establishment of a team of multidisciplinary and interdepartmental
investigators working in a highly collaborative and technology-driven environment.
The Center will strongly encourage research and development of new immunological approaches for prevention, detection
and treatment of human diseases, including cancer. The Center will be based primarily
in Abilene and staffed initially with faculty from both departments of the School
of Pharmacy. Research technologies at the Center will include but not limited to:
1) gene expression and protein engineering technologies, 2) hybridoma generation for
monoclonal antibodies, 3) pre-clinical research for evaluation of experimental therapeutics
(clinical pharmacology), 4) conjugation sciences, 5) microscopy and flow-cytometry,
and 6) a Human Immunology Core (HIC) to provide high-thru-put analysis of blood and
tissue specimens and to provide support for immune monitoring of patients participating
in clinical trials focused on cancer treatment and immune interventions. The HIC
will establish collaboration with clinical investigators interested in the development
of methodologies and monitoring devices. Center members will be encouraged to pursue
commercialization of their research discoveries and inventions. Center members will
collaborate with faculty and staff at the School of Pharmacy in Amarillo, Lubbock
and Dallas and with clinical and basic science departments across the nation. The
Center laboratory will provide pre-clinical support and testing of immunopharmaceuticals
and will be GLP compliant. The Center will interface with biotech companies in Abilene
and across the nation.
Jon A. Weidanz, M.P.H., Ph.D (Biomedical Sciences Dept.)
Magdalena Karbowniczek, M.D., Ph.D. (Biomed Dept)
Maciej Markiewski, M.D., Ph.D. (Biomed Dept)
Ninh (Irene) La-Beck, Pharm.D. (Pharmacy Practice Dept)